(HealthDay)—Farxiga (dapagliflozin) oral tablets are now approved for adults with chronic kidney disease at risk for disease progression, the U.S. Food and Drug Administration announced Friday.
Menu
Farxiga approved to reduce risk for CKD progression
Share:
Facebook
Twitter
Pinterest
LinkedIn
Categories
Menu
Related Posts
Vitamins and Minerals
Vitamins and minerals are micronutrients required by the body to carry out a range of normal functions. However, these micronutrients are not produced in our
What Vitamins and Minerals Do You Need Daily?
Macronutrients hog the spotlight. Everyone is talking about eating the right amount of proteins, fats, and carbohydrates for fitness goals, but there’s another type of
Convenient, Cheap, and Clean: The Best Home Gym Equipment
Commercial gyms are closed for at least the next couple of months due to the coronavirus outbreak. As a result, people are left scrambling to
6 Proven Ways to Increase Male Hormone Levels Naturally
Low testosterone is no joke. Did you know that testosterone levels in men have been on a steady decline since the 1980s? One study found
Menu